RT Journal Article SR Electronic T1 Detection of parasite-derived transrenal DNA for the diagnosis of chronic Trypanosoma cruzi infection JF medRxiv FD Cold Spring Harbor Laboratory Press SP 19010934 DO 10.1101/19010934 A1 Madrigal, Ana G. A1 Marcus, Rachel A1 Gilman, Robert A1 Scott, Alan L. A1 Shiff, Clive YR 2019 UL http://medrxiv.org/content/early/2019/11/25/19010934.abstract AB Chagas disease, caused by the protozoan parasite Trypanosoma cruzi, is a potentially life-threatening infection endemic to Latin America that has emerged as a global public health issue due to globalization and emigration patterns. Diagnosis of T. cruzi infection is complex, especially for the chronic phase of the disease that is characterized by a low to moderate burden of the difficult to detect, tissue-dwelling, intracellular form of the parasite. Diagnosis relies on a multistep indirect serological detection approach that requires positive results in at least two independent anti-T. cruzi antibody tests. With no gold standard diagnostic method for chronic T. cruzi, new approaches are needed that can more directly test for the presence of the parasite. Here, we report on of the potential utility of a noninvasive diagnostic approach that specifically detects T. cruzi-derived cell-free repeat DNA in the urine of patients who are both serologically positive and negative.Competing Interest StatementThe authors have declared no competing interest.Clinical Trialnot a clinical trialFunding StatementInternal departmental fundsAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data are available in the form a thesis written by the first author